12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga·03/28/2025 12:05:48

Listen to the news

Gainers

Portage Biotech (NASDAQ:PRTG) stock rose 158.8% to $12.19 during Friday's pre-market session. The market value of their outstanding shares is at $20.0 million.
Lexicon Pharmaceuticals (NASDAQ:LXRX) stock rose 106.53% to $0.72. The company's market cap stands at $259.5 million.
DBV Technologies (NASDAQ:DBVT) shares moved upwards by 61.12% to $6.3. The company's market cap stands at $129.2 million.
Prelude Therapeutics (NASDAQ:PRLD) shares increased by 17.14% to $0.8. The company's market cap stands at $44.0 million.
TransCode Therapeutics (NASDAQ:RNAZ) stock moved upwards by 15.59% to $0.6.
Iridex (NASDAQ:IRIX) stock increased by 15.51% to $1.02. The company's market cap stands at $16.9 million. As per the press release, Q4 earnings came out yesterday.

Losers

Milestone Pharmaceuticals (NASDAQ:MIST) stock fell 61.8% to $0.86 during Friday's pre-market session. The company's market cap stands at $45.8 million.
LogicMark (NASDAQ:LGMK) shares declined by 24.12% to $0.04. The market value of their outstanding shares is at $1.0 million.
Protagenic Therapeutics (NASDAQ:PTIX) stock decreased by 24.0% to $0.19. The company's market cap stands at $1.3 million.
Dermata Therapeutics (NASDAQ:DRMA) shares decreased by 20.43% to $1.13. The company's market cap stands at $6.1 million.
Sera Prognostics (NASDAQ:SERA) stock fell 20.26% to $3.11. The company's market cap stands at $117.1 million.
Design Therapeutics (NASDAQ:DSGN) shares declined by 16.23% to $3.51. The company's market cap stands at $199.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English